Shortage of black fungus drug
Date: 27 May 2021 Tags: MiscellaneousIssue
The increasing cases of black fungus have created shortages of liposomal Amphotericin B used as a primary drug in treating the infection.
Background
Mucormyosis, also known as black fungus, is one of the most widely observed post-covid symptoms across the globe.
Details
-
The drug has been gaining demand from desperate relatives of patients. This has resulted in hoarding and black marketing.
-
The black fungus disease is a rare fungal infection. It is estimated to infect about 140 people per million in India. It is the joint highest rate of infection in the world.
-
Doctors and experts have pointed irrational use of steroids as a possible reason for such high rate of disease in India.
Treatment of infection
-
The diagnosis and treatment has to be quick if the survival rate has to increase. Drugs as well as surgery can remove fungus from the body.
-
Drugs used in treatment include posaconazole, isavuconazole, and Amphotericin B deoxycholate along with preferred liposomal Amphotericin B
-
Amphotericin B deoxycholate is an effective treatment drug but is known to cause kidney damage. It is recommended to patients having no kidney ailments.